Puretech Health Share Discussion Threads

[gbh2] 19/7/2016 07:57

Based on last years financial announcements we Should be due some results this month.

[gbh2] 13/7/2016 11:35

Read it but I still can't make my mind up as to whether this is a cash cow for old, ex pharma directors, or if it's a potential winner, guess time will tell.

[bergsy] 12/7/2016 18:59

Buy reiterated buy Peel Hunt see link.

hxxp://www.dailypolitical.com/2016/07/12/peel-hunt-reiterates-buy-rating-for-puretech-health-plc-prtc/

[gbh2] 12/7/2016 17:01

Looked to me as it had been moved between accounts.

[bergsy] 12/7/2016 16:26

SP movement could be due to the earlier RNS from tody, from my understanding of the RNS there has been a transfer of shares between two entities, but from what I can understand it's between the same person ???? Can anyone enlighten me on the RNS?

[gbh2] 12/7/2016 14:12

Looks to be some dodgy MM moves with sp!

[bergsy] 12/7/2016 11:37

Just added a few here. Hopefully it will be a steady climber over the next few months.

[gbh2] 11/7/2016 14:28

Picked a few up on the off chance.

[elgordo] 10/7/2016 12:15

Thanks, dice; have included in the header.

[dice1950] 10/7/2016 07:40

MIDAS SHARE TIPS: From obesity to hair-loss… tech firm PureTech is turning concept into cure
10th July 2016

[elgordo] 01/7/2016 13:21

Surprised to find no thread for this, so, having bought in, here one is...

[elgordo] 01/7/2016 13:20

PureTech’s businesses originate from a systematic and rigorous theme-driven process, including an unbiased analysis of more than 650 scientific discoveries per year. This process has resulted in an advanced pipeline of seven growth stage businesses, five project phase businesses and 10 concept phase initiatives.

PureTech is focused on areas that it believes have reached an inflection point. While not limited to these areas, PureTech’s current focus is on the immune system, the central nervous system (brain), the gastrointestinal system (gut), and the signaling and interfaces between these systems.


10 July 2016 - Mail on Sunday Midas share tip - "From obesity to hair-loss... US firm PureTech turning concept into cure". Midas verdict: PureTech is valued on the stock market at £350million yet some of its individual businesses could be worth two or three times more than that. This is not a stock for short-term shareholders worried about Brexit-induced volatility. But for long-term investors, the shares, at 142p, could prove to be a real bargain.